What this assignment does
The assignment follows CRISPR-Cas9 from its biological origin to its clinical and ethical present. It opens with the bacterial adaptive-immunity system — acquisition, expression, interference — then works through the molecular mechanism in detail: PAM recognition, R-loop formation, the seed region, the two nuclease domains, and the blunt double-strand break. It then explains how the two cellular repair pathways are co-opted for knockout and for precise editing respectively.
From there it widens twice. First technically, into the second-generation tools built on a catalytically impaired Cas9 — base editing, prime editing, CRISPRi and CRISPRa — explaining each as a response to a specific limitation of the first generation rather than as a newer thing. Then clinically, through the BCL11A-enhancer strategy behind the first approved CRISPR therapy for sickle cell disease and β-thalassaemia, CAR-T applications, diagnostics and genome-wide screens.
The final third is where the assignment takes its risks and wins. Off-target activity and delivery are treated as the two real obstacles, with the ex vivo / in vivo distinction used to explain why the earliest clinical successes look the way they do. The ethics section then runs on a single distinction — somatic versus germline — and uses the 2018 embryo-editing episode as evidence about governance rather than as a story.
How it is built
The full section list, in order. Read it before you read the extracts: a large part of what makes this document work is the decision about what goes where, and that is visible in the contents alone.
- Abstract
- 1. Introduction
- 2. Biological Origin: A Bacterial Adaptive Immune System
- 3. Molecular Mechanism of Cas9 — target recognition and the PAM; DNA cleavage; exploiting DNA repair; guide RNA design and specificity determinants
- 4. Expanding the Toolbox
- 5. Therapeutic Applications
- 6. Limitations and Challenges — off-target effects and delivery
- 7. Ethical Considerations
- 8. Conclusion
- References
c. 2,050 words, Harvard (author–date) referencing, 13 sources cited.
Annotated extracts
Three passages, quoted from the document, each followed by the reasoning a marker would apply to it and by what a weaker answer tends to do in the same place. The extracts are deliberately short — enough to teach the move, not enough to stand in for the assignment.
The transformative advantage of CRISPR over earlier genome-editing platforms lies in how specificity is achieved. Zinc-finger nucleases and TALENs recognise DNA through modular proteins that must be re-engineered for every new target, a slow and technically demanding process. CRISPR-Cas9 instead separates recognition from cleavage: the constant Cas9 protein provides the nuclease activity, while a short, interchangeable guide RNA supplies target specificity through simple Watson–Crick base pairing. Redirecting the system to a new site therefore requires only the synthesis of a new guide RNA rather than the engineering of a new protein. Moreover, because several guides can be delivered together, CRISPR permits multiplexed editing of multiple genes simultaneously—an approach impractical with protein-based nucleases.
Why this marks well
This is what “critically evaluate” looks like when it is done properly in a molecular biology assignment. The comparison is not decorative: the writer names the alternatives, isolates the single structural difference that matters (specificity moved out of protein and into RNA), and then derives two consequences from it — ease of retargeting, and multiplexing.
Deriving a second, non-obvious consequence is the part that lifts the mark. Anyone can say CRISPR is easier to retarget. Noticing that the same architectural choice is what makes simultaneous multi-gene editing possible shows the student has understood the architecture rather than the headline.
The paragraph is also well placed. It sits at the end of the biology-origin section, so it converts background into justification: it explains why the rest of the assignment is about this system and not about TALENs. Background that argues for its own relevance almost never reads as padding.
What a weaker answer does here
A weaker answer mentions that zinc-finger nucleases and TALENs came first and were harder to use, usually in a single clause, and moves on. The comparison is present but does no work, so the section reads as history rather than as an argument about design.
Cas9 possesses two nuclease domains that each cut one strand of the DNA. The HNH domain cleaves the target strand that is complementary to the guide RNA, while the RuvC-like domain cleaves the non-target strand. Concerted action produces a blunt-ended double-strand break (DSB) typically three base pairs upstream of the PAM. It is this precisely positioned DSB that the cell must repair, and it is the repair process—not Cas9 itself—that produces the genetic edit.
Why this marks well
The final clause is worth the whole paragraph. “It is the repair process — not Cas9 itself — that produces the genetic edit” corrects the single most common misunderstanding in undergraduate CRISPR answers, which is that the enzyme does the editing. One sentence, placed exactly where the reader is about to form the wrong belief.
It is also a structural hinge. Having said that repair produces the edit, the assignment has no choice but to explain the repair pathways next, and section 3.3 duly does. Sentences that create an obligation the next section discharges are how an essay reads as planned.
The level of specificity is calibrated rather than maximal — two named domains, which strand each cuts, blunt ends, three base pairs upstream of the PAM. Enough to prove the mechanism is understood, short enough that the conceptual point still lands. Detail without a conceptual payoff is where word counts quietly die.
What a weaker answer does here
A weaker answer says Cas9 cuts the DNA at the site specified by the guide RNA and thereby edits the gene. It is not exactly wrong, but it conceals the fact that the edit is a repair outcome, and everything downstream — why knockout is easy and precise correction is hard — then becomes impossible to explain.
A crucial distinction separates somatic editing, which affects only the treated individual, from germline editing, which alters the DNA of gametes or embryos and is therefore heritable. Somatic therapy is broadly regarded as an extension of accepted medical practice, subject to the usual standards of safety and consent. Germline editing, by contrast, affects future generations who cannot consent, carries the risk of transmitting unintended edits, and raises the prospect of non-therapeutic “enhancement” and the exacerbation of social inequity.
Why this marks well
The ethics section is built on a distinction, not on a position. Somatic versus germline is introduced first, and every subsequent concern — consent, heritable error, enhancement, equity — is attached to one side of it. That is analysis. A moral opinion, however reasonable, is not, and in a biomedical science assignment it tends to be marked as such.
The three objections to germline editing are also well chosen, because they are different kinds of objection: one about consent, one about technical risk, one about social consequence. Listing three versions of the same worry is a common way to look thorough while covering one point.
What follows in the source document is equally disciplined: the 2018 embryo-editing case is used as evidence about the state of governance and attributed to a published source, rather than retold as a story. Ethics sections lose marks almost entirely by becoming unreferenced.
What a weaker answer does here
A weaker answer writes a closing paragraph arguing that genome editing raises serious ethical questions and must be carefully regulated. Nothing in it is false and nothing in it is assessable, because no distinction is drawn and no claim is sourced.
What makes this a strong answer
Pulling the annotations together. None of these are subject-specific tricks; they are what UK undergraduate marking criteria mean by explanation and critical engagement.
- Background that justifies its own presence — the origin section ends by explaining why this system, and not its predecessors, is the subject of the assignment.
- A comparative evaluation that isolates one structural difference and derives more than one consequence from it.
- Second-generation tools introduced as answers to stated limitations, which makes the technical section an argument rather than a catalogue.
- One sentence placed to pre-empt the commonest conceptual error, rather than a correction buried later.
- An ethics section organised by an analytic distinction and referenced to the same standard as the molecular sections.
Request the full document
Request the full document
The extracts above are the teaching material and they stay on this page. The complete 2,050-word document is sent person to person, by a human, after a short conversation about what you are working on — so that we can point you at the right parts of it rather than hand over a file and wish you luck.
Both links below already name this sample (BMS-03), so you do not have to describe it.
WhatsApp · +44 7537 126 976 · Email · mia@globalprojectshelp.com
Mon–Sat, 9–22 GMT. No form, no mailing list, no download gate.
Full documents are never published, hosted or linked on this site.
Using this sample honestly
This is a worked example. It sits in the same place as a worked example in a textbook or a past paper with an examiner’s report attached: read it, take the move, then write your own paragraph without it open in another window.
Submitting any part of this document as your own work would be plagiarism — the same offence as copying from a journal article, and detected the same way. If you draw on it, cite it. If a deadline has got to the point where submitting someone else’s paragraph feels like an option, say so when you message us; that is a problem with a legitimate answer and we would rather work on it than watch it happen.
Our full position, including how to declare mentoring support to your institution, is on the academic integrity policy page.
Where to go next
- More biomedical science samples The other three assignments in this set, each annotated the same way.
- All samples Every annotated model answer in the library, with discipline filters.
- How requesting works What you receive, what you do not, and the conditions attached.
- Academic integrity policy What we do, what we will not do, and how to declare mentoring support.
Model answer written by a Global Projects Help mentor · © Global Projects Help
Published 8 October 2026 · Questions? mia@globalprojectshelp.com